The Effect of Diabetes Mellitus on the Prognosis of Patients With COVID-19

Last updated: May 1, 2021
Sponsor: Uşak University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Diabetes Prevention

Diabetes And Hypertension

Treatment

N/A

Clinical Study ID

NCT04591704
UU-DM003
  • Ages 18-80
  • All Genders

Study Summary

All hospitalised patients with COVID-19 who have positive RT-PCR for SARS-COV-2 will be included in the study.

The patients will be divided into two groups, as diabetics and non-diabetics. The COVID-19 patients' medical records will be evaluated and compared in terms of the duration of hospitalization, the presence of lung involvement in Computerised Tomography, the need for intensive care unit and mortality rates in patients with and without diabetes.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients hospitalized for COVID-19

Exclusion

Exclusion Criteria:

  • Patients with known malignancy
  • Pregnant patients

Study Design

Total Participants: 2000
Study Start date:
March 20, 2020
Estimated Completion Date:
July 01, 2021

Study Description

All hospitalised patients with COVID-19 who have positive RT-PCR for SARS-COV-2 will be included in the study.

The patients will be divided into two groups, as diabetics and non-diabetics. The diagnosis of diabetes mellitus will be extracted from the medical records and medical history of the patients hospitalised with COVID-19.

The COVID-19 patients medical records will be evaluated and compared in terms of the duration of hospitalization, the presence of lung involvement in Computerised Tomography, the need for intensive care unit and mortality rates in patients with and without diabetes.

Connect with a study center

  • Usak University Training and Research Hospital

    Usak, 64200
    Turkey

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.